NEW YORK, Sept. 18 — NaPro BioTherapeutics of Boulder, Col., said it recently established a genomics division, NaPro Genomics, under the scientific direction of Eric Kmiec at the University of Delaware’s Delaware Biotechnology Institute. Kmiec, who invented and developed a targeted gene repair technology that NaPro licensed, directs g enomics research at the institute and is an associate professor in the university’s department of biological sciences.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.